Taro Pharmaceutical Industries Ltd reports results for the quarter ended in June - Earnings Summary

Taro Pharmaceutical Industries

28/07/2022 20:44

* Taro Pharmaceutical Industries Ltd  TARO.N  reported
quarterly
adjusted earnings of 37 cents​​ per share for the quarter ended
in June. The lone analyst forecast for the quarter was
for earnings of 85 cents per share.
    * Revenue rose 6.5% to $156.67 million from a year ago;
analysts
expected $149.88 million. 
    * Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was 37 cents​.
    * The mean earnings estimate of analysts had fallen by
about 13.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Taro Pharmaceutical Industries Ltd shares had risen
by 0.9% this
quarter and lost 27.2% so far this year.
    * The company reported quarterly net income of $14.08
million.
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $73.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data July 28
at 07:44 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      0.85           0.37           Missed
 Mar. 31 2022      0.88           0.73           Missed
 Dec. 31 2021      0.91           0.70           Missed
 Sep. 30 2021      1.02           0.66           Missed